ResearcherLMU KlinikumActive in the last 2 years
Marlies Vornhülz
Matched on ORCID iD 0000-0003-1197-0419; OpenAlex author ID A5110838430. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2022: 3 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 7
- Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multic… Co-author DOI 10.1016/s2468-1253(25)00056-1↗
- Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report. Co-author DOI 10.1159/000545975↗
- Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. Co-author DOI 10.1016/j.ctro.2024.100738↗
- [Pancreatic cancer-screening or surveillance?] First author DOI 10.1007/s00117-023-01227-3↗
- Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancr… Co-author DOI 10.1053/j.gastro.2022.07.047↗
- MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open rand… Co-author DOI 10.1186/s13014-022-01988-6↗
- Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review. Co-author DOI 10.1186/s13014-022-02076-5↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Georg Beyer · 6 shared papers, 2022–2025 · strength 1.04
- Paper [Pancreatic cancer-screening or surveillance?] DOI 10.1007/s00117-023-01227-3↗
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975↗
- Paper Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. DOI 10.1016/j.ctro.2024.100738↗
- Julia V. Mayerle · 5 shared papers, 2022–2025 · strength 0.84
- Paper [Pancreatic cancer-screening or surveillance?] DOI 10.1007/s00117-023-01227-3↗
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975↗
- Paper Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarci… DOI 10.1186/s13014-022-02076-5↗
- Maximilian Niyazi · 4 shared papers, 2022–2025 · strength 0.69
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975↗
- Paper Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data. DOI 10.1016/j.ctro.2024.100738↗
- Paper Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarci… DOI 10.1186/s13014-022-02076-5↗
- Simon Sirtl · 3 shared papers, 2022–2025 · strength 0.55
- Paper [Pancreatic cancer-screening or surveillance?] DOI 10.1007/s00117-023-01227-3↗
- Paper Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Te… DOI 10.1159/000545975↗
- Paper Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic … DOI 10.1053/j.gastro.2022.07.047↗
- Paul Rogowski · 2 shared papers, 2024–2025 · strength 0.41
- Christoph Benedikt Westphalen · 2 shared papers, 2024–2025 · strength 0.41
- Ivonne Regel · 2 shared papers, 2022 · strength 0.26
- Paper Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarci… DOI 10.1186/s13014-022-02076-5↗
- Paper Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic … DOI 10.1053/j.gastro.2022.07.047↗
- Kathrin Heinrich · 1 shared paper, 2025 · strength 0.21
- Volker Heinemann · 1 shared paper, 2025 · strength 0.21
- Alexander Kleger · 1 shared paper, 2025 · strength 0.21
- Mohamed A. Shouman · 1 shared paper, 2024 · strength 0.20
- Péter Jenő Hegyi · 1 shared paper, 2022 · strength 0.15
- Matea Pavic · 1 shared paper, 2022 · strength 0.13
- Jürgen Debus · 1 shared paper, 2022 · strength 0.13
- Ralph Fritsch · 1 shared paper, 2022 · strength 0.13
- Matthias Gückenberger · 1 shared paper, 2022 · strength 0.13
- Elisabetta Goni · 1 shared paper, 2022 · strength 0.11
- Waldemar H. Uhl · 1 shared paper, 2022 · strength 0.11
- Fritz Klein · 1 shared paper, 2022 · strength 0.11
- Frank Ulrich Weiß · 1 shared paper, 2022 · strength 0.11
- Robert Grützmann · 1 shared paper, 2022 · strength 0.11
- Roland Rad · 1 shared paper, 2022 · strength 0.11
- John P. Neoptolemos · 1 shared paper, 2022 · strength 0.11
- Holger Kalthoff · 1 shared paper, 2022 · strength 0.11
- Markus M. Lerch · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.